Figure 2
From: Recombinant production of the therapeutic peptide lunasin
Expression strategy of the CBD-lunasin fusion protein and subsequent TEV cleavage. The arrangement of regions of the construct are shown. Lunasin peptide released following TEV cleavage has the native sequence as the N-terminal serine residue is provided by the TEV protease recognition sequence. Also indicated are the expected sizes of the resulting fragments.